Essential Role for ADAM19 in Cardiovascular Morphogenesis

Molecular and Cellular Biology

Volumn 24, Issue 1, 2004, Pages 96-104

  Zhou, Hong Ming ^a   Weskamp, Gisela ^a   Chesneau, Valérie ^a   Sahin, Umut ^a,b   Vortkamp, Andrea ^c   Horiuchi, Keisuke ^a   Chiusaroli, Riccardo ^d   Hahn, Rebecca ^a   Wilkes, David ^a   Fisher, Peter ^e   Baron, Roland ^d   Manova, Katia ^a   Basson, Craig T ^a   Hempstead, Barbara ^a   Blobel, Carl P ^a,f  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BROWN UNIVERSITY   (United States)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISINTEGRIN; MEMBRANE PROTEIN; METALLOPROTEINASE; OSTEOPROTEGERIN;

ANIMAL CELL; ARTICLE; BIRTH DEFECT; BONE DEVELOPMENT; BONE GROWTH; CARDIOVASCULAR RESPONSE; CELL DIFFERENTIATION; CONGENITAL HEART DISEASE; CYTOKINE RELEASE; GENE MUTATION; IMMUNOHISTOCHEMISTRY; MORPHOGENESIS; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NONHUMAN; OSTEOBLAST; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN SECRETION;

ADAM PROTEINS; ANIMALS; BLOTTING, WESTERN; BONE DEVELOPMENT; BRAIN; CARDIOVASCULAR SYSTEM; DISINTEGRINS; LUNG; MEMBRANE PROTEINS; METALLOPROTEASES; MICE;

ANIMALIA;

EID: 10744223754     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.1.96-104.2004     Document Type: Article

References (53)

1. Alfandari, D., H. Cousin, A. Gaultier, K. Smith, J. M. White, T. Darribere, and D. W. DeSimone. 2001. Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration. Curr. Biol. 11:918-930.
2. Basson, C. T., and C. E. Seidman. 1998. Genetic studies of myocardial and vascular disease, p. 2429-2447. In E. J. Topol (ed.), Textbook of cardiovascular medicine. Lippincott-Raven, Philadelphia, Pa.
3. Black, R. A., and J. M. White. 1998. ADAMs: focus on the protease domain. Curr. Opin. Cell Biol. 10:654-659.
4. Blobel, C. P. 2000. Remarkable roles of proteolysis on and beyond the cell surface. Curr. Opin. Cell Biol. 12:606-612.
5. Brown, C. B., A. S. Boyer, R. B. Runyan, and J. V. Barnett. 1999. Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science 283:2080-2082.
6. Camenisch, T. D., D. G. Molin, A. Person, R. B. Runyan, A. C. Gittenberger-de Groot, J. A. McDonald, and S. E. Klewer. 2002. Temporal and distinct TGFbeta ligand requirements during mouse and avian endocardial cushion morphogenesis. Dev. Biol. 248:170-181.
7. Chesneau, V., D. Becherer, Y. Zheng, H. Erdjument-Bromage, P. Tempst, and C. P. Blobel. 2003. Catalytic properties of ADAM19. J. Biol. Chem. 278:22331-22340.
8. Chien, K. R. 2000. Genomic circuits and the integrative biology of cardiac diseases. Nature 407:227-232.
9. Deftos, M. L., E. Huang, E. W. Ojala, K. A. Forbush, and M. J. Bevan. 2000. Notch1 signaling promotes the maturation of CD4 and CD8 SP thymocytes. Immunity 13:73-84.
10. Donovan, M. J., R. Hahn, L. Tessarollo, and B. L. Hempstead. 1996. Identification of an essential nonneuronal function of neurotrophin 3 in mammalian cardiac development. Nat. Genet. 14:210-213.
11. Falls, D. L. 2003. Neuregulins: functions, forms, and signaling strategies. Exp. Cell Res. 284:14-30.
12. Fata, J. E., Y. Y. Kong, J. Li, T. Sasaki, J. Irie-Sasaki, R. A. Moorehead, R. Elliott, S. Scully, E. B. Voura, D. L. Lacey, W. J. Boyle, R. Khokha, and J. M. Penninger. 2000. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 103:41-50.
13. Fritsche, J., M. Moser, S. Faust, A. Peuker, R. Buttner, R. Andreesen, and M. Kreutz. 2000. Molecular cloning and characterization of a human metalloprotease disintegrin-a novel marker for dendritic cell differentiation. Blood 96:732-739.
14. Galvin, K. M., M. J. Donovan, C. A. Lynch, R. I. Meyer, R. J. Paul, J. N. Lorenz, V. Fairchild-Huntress, K. L. Dixon, J. H. Dunmore, M. A. Gimbrone, Jr., D. Falb, and D. Huszar. 2000. A role for smad6 in development and homeostasis of the cardiovascular system. Nat. Genet. 24:171-174.
15. Goldmuntz, E., and B. S. Emanuel. 1997. Genetic disorders of cardiac morphogenesis. The DiGeorge and velocardiofacial syndromes. Circ. Res. 80:437-443.
16. Gruber, P. J., S. W. Kubalak, T. Pexieder, H. M. Sucov, R. M. Evans, and K. R. Chien. 1996. RXR alpha deficiency confers genetic susceptibility for aortic sac, conotruncal, atrioventricular cushion, and ventricular muscle defects in mice. J. Clin. Investig. 98:1332-1343.
17. Horiuchi, K., G. Weskamp, L. Lum, H. P. Hammes, H. Cai, T. A. Brodie, T. Ludwig, R. Chiusaroli, R. Baron, K. T. Preissner, K. Manova, and C. P. Blobel. 2003. Potential role for ADAM15 in pathological neovascularization in mice. Mol. Cell. Biol. 23:5614-5624.
18. Inoue, D., M. Reid, L. Lum, J. Krätzschmar, G. Weskamp, Y. M. Myung, R. Baron, and C. P. Blobel. 1998. Cloning and initial characterization of mouse meltrin beta and analysis of the expression of four metalloprotease-disintegrins in bone cells. J. Biol. Chem. 273:4180-4187.
19. Iwamoto, R., S. Yamazaki, M. Asakura, S. Takashima, H. Hasuwa, K. Miyado, S. Adachi, M. Kitakaze, K. Hashimoto, G. Raab, D. Nanba, S. Higashiyama, M. Hori, M. Klagsbrun, and E. Mekada. 2003. Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function. Proc. Natl. Acad. Sci. USA 100:3221-3226.
20. Jackson, L. F., T. H. Qiu, S. W. Sunnarborg, A. Chang, C. Zhang, C. Patterson, and D. C. Lee. 2003. Defective valvulogenesis in HB-EGF and TACE-null mice is associated with aberrant BMP signaling. EMBO J. 22:2704-2716.
21. Jerome, L. A., and V. E. Papaioannou. 2001. DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1. Nat. Genet. 27:286-291.
22. Kang, T., Y. G. Zhao, D. Pei, J. F. Sucic, and Q. X. Sang. 2002. Intracellular activation of human adamalysin 19/disintegrin and metalloproteinase 19 by furin occurs via one of the two consecutive recognition sites. J. Biol. Chem. 277:25583-25591.
23. Kim, R. Y., E. J. Robertson, and M. J. Solloway. 2001. Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. Dev. Biol. 235:449-466.
24. Kirby, M. L. 1999. Contribution of neural crest to heart and vessel morphology, p. 179-193. In R. P. Harvey and N. Rosenthal (ed.), Heart development. Academic Press, London, United Kingdom.
25. Kong, Y. Y., H. Yoshida, I. Sarosi, H. L. Tan, E. Timms, C. Capparelli, S. Morony, A. J. Oliveira-dos-Santos, G. Van, A. Itie, W. Khoo, A. Wakeham, C. R. Dunstan, D. L. Lacey, T. W. Mak, W. J. Boyle, and J. M. Penninger. 1999. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
26. Kramer, R., N. Bucay, D. J. Kane, L. E. Martin, J. E. Tarpley, and L. E. Theill. 1996. Neuregulins with an Ig-like domain are essential for mouse myocardial and neuronal development. Proc. Natl. Acad. Sci. USA 93:4833-4838.
27. Kurisaki, T., A. Masuda, N. Osumi, Y. Nabeshima, and A. Fujisawa-Sehara. 1998. Spatially- and temporally-restricted expression of meltrin alpha (ADAM12) and beta (ADAM19) in mouse embryo. Mech. Dev. 73:211-215.
28. Lacey, D. L., E. Timms, H. L. Tan, M. J. Kelley, C. R. Dunstan, T. Burgess, R. Elliott, A. Colombero, G. Elliott, S. Scully, H. Hsu, J. Sullivan, N. Hawkins, E. Davy, C. Capparelli, A. Eli, Y. X. Qian, S. Kaufman, I. Sarosi, V. Shalhoub, G. Senaldi, J. Guo, J. Delaney, and W. J. Boyle. 1998. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
29. Lamers, W. H., and A. F. Moorman. 2002. Cardiac septation: a late contribution of the embryonic primary myocardium to heart morphogenesis. Circ. Res. 91:93-103.
30. Leighton, P. A., K. J. Mitchell, L. V. Goodrich, X. Lu, K. Pinson, P. Scherz, W. C. Skarnes, and M. Tessier-Lavigne. 2001. Defining brain wiring patterns and mechanisms through gene trapping in mice. Nature 410:174-179.
31. Lindsay, E. A., F. Vitelli, H. Su, M. Morishima, T. Huynh, T. Pramparo, V. Jurecic, G. Ogunrinu, H. F. Sutherland, P. J. Scambler, A. Bradley, and A. Baldini. 2001. Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice. Nature 410:97-101.
32. Lum, L., and C. P. Blobel. 1997. Evidence for distinct serine protease activities with a potential role in processing the sperm protein fertilin. Dev. Biol. 191:131-145.
33. Manova, K., K. Nocka, P. Besmer, and R. F. Bachvarova. 1990. Gonadal expression of c-kit encoded at the W locus of the mouse. Development 110:1057-1069.
34. Merlos-Suarez, A., S. Ruiz-Paz, J. Baselga, and J. Arribas. 2001. Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme. J. Biol. Chem. 276:48510-48517.
35. Merscher, S., B. Funke, J. A. Epstein, J. Heyer, A. Puech, M. M. Lu, R. J. Xavier, M. B. Demay, R. G. Russell, S. Factor, K. Tokooya, B. S. Jore, M. Lopez, R. K. Pandita, M. Lia, D. Carrion, H. Xu, H. Schorle, J. B. Kobler, P. Scambler, A. Wynshaw-Boris, A. I. Skoultchi, B. E. Morrow, and R. Kucherlapati. 2001. TBX1 is responsible for cardiovascular defects in velocardio-facial/DiGeorge syndrome. Cell 104:619-629.
36. Meyer, D., and C. Birchmeier. 1995. Multiple essential functions of neuregulin in development. Nature 378:386-390.
37. Primakoff, P., and D. G. Myles. 2000. The ADAM gene family: surface proteins with an adhesion and protease activity packed into a single molecule. Trends Genet. 16:83-87.
38. Rentschler, S., J. Zander, K. Meyers, D. France, R. Levine, G. Porter, S. A. Rivkees, G. E. Morley, and G. I. Fishman. 2002. Neuregulin-1 promotes formation of the murine cardiac conduction system. Proc. Natl. Acad. Sci. USA 99:10464-10469.
39. Schlöndorff, J., and C. P. Blobel. 1999. Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein ectodomain shedding. J. Cell Sci. 112:3603-3617.
40. Schlöndorff, J. S., L. Lum, and C. P. Blobel. 2001. Biochemical and pharmacological criteria define two shedding activities for TRANCE/OPGL that are distinct from the TNF alpha convertase (TACE). J. Biol. Chem. 276:14665-14674.
41. Seals, D. F., and S. A. Courtneidge. 2003. The ADAMs family of metalloproteases: multidomain proteins with multiple functions. Genes Dev. 17:7-30.
42. Shirakabe, K., S. Wakatsuki, T. Kurisaki, and A. Fujisawa-Sehara. 2001. Roles of meltrin beta/ADAM19 in the processing of neuregulin. J. Biol. Chem. 276:9352-9358.
43. Srivastava, D., and E. N. Olson. 2000. A genetic blueprint for cardiac development. Nature 407:221-226.
44. Sunnarborg, S. W., C. L. Hinkle, M. Stevenson, W. E. Russell, C. S. Raska, J. J. Peschon, B. J. Castner, M. J. Gerhart, R. J. Paxton, R. A. Black, and D. C. Lee. 2002. Tumor necrosis factor-alpha converting enzyme (TACE) regulates epidermal growth factor receptor ligand availability. J. Biol. Chem. 277:12838-12845.
45. Suzuki, T., Q. Yan, and W. J. Lennarz. 1998. Complex, two-way traffic of molecules across the membrane of the endoplasmic reticulum. J. Biol. Chem. 273:10083-10086.
46. Tokumaru, S., S. Higashiyama, T. Endo, T. Nakagawa, J. Miyagawa, K. Yamamori, Y. Hanakawa, H. Ohmoto, K. Yoshino, Y. Shirakata, Y. Matsuzawa, K. Hashimoto, and N. Taniguchi. 2000. Ectodomain shedding of epidermal growth factor receptor ligands is required for keratinocyte migration in cutaneous wound healing. J. Cell Biol. 151:209-220.
47. Vaughan, C. J., and C. T. Basson. 2000. Molecular determinants of atrial and ventricular septal defects and patent ductus arteriosus. Am. J. Med. Genet. 97:304-309.
48. Vu, T. H., J. M. Shipley, G. Bergers, J. E. Berger, J. A. Helms, D. Hanahan, S. D. Shapiro, R. M. Senior, and Z. Werb. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93:411-422.
49. Wei, P., Y. G. Zhao, L. Zhuang, S. Ruben, and Q. X. Sang. 2001. Expression and enzymatic activity of human disintegrin and metalloproteinase ADAM19/meltrin beta. Biochem. Biophys. Res. Commun. 280:744-755.
50. Weskamp, G., H. Cai, T. A. Brodie, S. Higashyama, K. Manova, T. Ludwig, and C. P. Blobel. 2002. Mice lacking the metalloprotease-disintegrin MDC9 (ADAM9) have no evident major abnormalities during development or adult life. Mol. Cell. Biol. 22:1537-1544.
51. Wilkinson, D. G., J. A. Bailes, J. E. Champion, and A. P. McMahon. 1987. A molecular analysis of mouse development from 8 to 10 days post coitum detects changes only in embryonic globin expression. Development 99:493-500.
52. Yagami-Hiromasa, T., T. Sato, T. Kurisaki, K. Kamijo, Y. Nabeshima, and A. Fujisawa-Sehara. 1995. A metalloprotease-disintegrin participating in myoblast fusion. Nature 377:652-656.
53. Zhao, Y. G., P. Wei, and Q. X. Sang. 2001. Inhibitory antibodies against endopeptidase activity of human adamalysin 19. Biochem. Biophys. Res. Commun. 289:288-294.